|
| Press Releases |
|
 |
|
| Tuesday, March 31, 2020 |
|
|
Kingworld Medicines Seizes the Opportunity Foster the Diversified Development of Product Specifications |
| Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a globally leading and well-known omni-channel enterprise with a complete supply chain in the greater healthcare products and services industry in China, has announced its unaudited annual results for the year ended 31 December 2019 (the "Year Under Review"). more info >> |
|
| Thursday, January 23, 2020 |
|
|
疫情牵动人心，预防为主 |
| 近日，全国人民的注意力都被一种快速传播的疾病——新型冠状病毒感染的肺炎牵制，受该病毒感染的患者一般会出现发热、乏力、干咳、逐渐出现呼吸困难，严重者出现急性呼吸窘迫综合症、脓毒症休克、难以纠正的代谢性酸中毒、出现凝血功能障碍、甚至死亡。 more info >> |
|
|
疫情牽動人心，預防為主 |
| 近日，全國人民的注意力都被一種快速傳播的疾病─新型冠狀病毒感染的肺炎牽制，受該病毒感染的患者一般會出現發熱、乏力、乾咳、逐漸出現呼吸困難，嚴重者出現急性呼吸窘迫綜合症、膿毒症休克、難以糾正的代謝性酸中毒、出現凝血功能障礙、甚至死亡。 more info >> |
|
| Tuesday, August 27, 2019 |
|
|
金活25周年稳步前进 逐健康追梦征程 |
中国领先及全球知名大健康产品服务的全渠道供应链企业 - 金活医药集团有限公司（「金活医药」或「集团」，股份代号：01110.HK）公布截至2019年6月30日止六个月（「回顾期」）未经审核之中期业绩。
more info >> |
|
|
金活25週年穩步前進 逐健康追夢征程 |
中國領先及全球知名大健康產品服務的全渠道供應鏈企業 - 金活醫藥集團有限公司（「金活醫藥」或「集團」，股份代號：01110.HK）公佈截至2019年6月30日止六個月（「回顧期」）未經審核之中期業績。
more info >> |
|
|
Steady Development in Kingworld 25th Anniversary and Deepening Management New Journey in Pursuit of Quality and Healthy Living |
Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a leading global well-known omni-channel enterprise offering a complete supply chain spanning the greater health products and services industry, has announced its unaudited interim results for the six months ended 30 June 2019 (the "Period").
more info >> |
|
| Thursday, March 28, 2019 |
|
|
金活医药强化销售策略与渠道覆盖 引进新产品优化结构 念慈菴枇杷膏销售大幅增长25.6% |
中国领先及全球知名大健康产品服务的全链条全渠道供应链企业 - 金活医药集团有限公司（「金活医药」或「集团」，股份代号：01110.HK）公布截至2018年12月31日止年度（「回顾年度」）经审核之全年业绩。
more info >> |
|
|
金活醫藥強化銷售策略與渠道覆蓋 引進新產品優化結構 念慈菴枇杷膏銷售大幅增長25.6% |
中國領先及全球知名大健康產品服務的全鏈條全渠道供應鏈企業 - 金活醫藥集團有限公司（「金活醫藥」或「集團」，股份代號：01110.HK）公佈截至2018年12月31日止年度（「回顧年度」）經審核之全年業績。
more info >> |
|
|
Kingworld Medicines Strengthening Sales Strategy and Channel Coverage; Optimizing Structure by Introducing New Products; Sales of Nin Jiom Significantly Increased by 25.6% |
Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a globally leading and well-known omni-channel enterprise with a complete supply chain in the greater health products and services industry in China, has announced its audited annual results for the year ended 31 December 2018 (the "Year Under Review").
more info >> |
|
| Wednesday, August 29, 2018 |
|
|
金活医药2018年上半年收益稳步提升，同比增长9.3%；本公司拥有人应占溢利上升24.4%至人民币2,755万元 |
中国领先及全球知名大健康产品服务的全链条全渠道供应链企业 - 金活医药集团有限公司（「金活医药」或「集团」，股份代号：01110.HK）欣然公布截至2018年6月30日止六个月（「回顾期」）未经审核之中期业绩。
more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
OSL Lists State-Supervised Gold-Backed Stablecoin USDKG as Platform Expands Asia's Digital Asset Ecosystem
May 22, 2026 23:30: JST
|
|
|
OSL Lists State-Supervised Gold-Backed Stablecoin USDKG as Platform Expands Asia's Digital Asset Ecosystem
May 22, 2026 22:30 HKT/SGT
|
|
|
Six Factors to Consider When Opting for a Credit Line in Singapore
May 22, 2026 19:05 HKT/SGT
|
|
|
Patents Build Solid Barriers, Technologies Achieve All-Round Breakthroughs, New Vision Leads the New Track of AR Interaction
May 22, 2026 17:46 HKT/SGT
|
|
|
天辰生物通過聆訊：深耕過敏與自身免疫領域 臨床療效全面領先
May 22, 2026 16:32 HKT/SGT
|
|
|
天辰生物通过聆讯：深耕过敏与自身免疫领域 临床疗效全面领先
May 22, 2026 16:32 HKT/SGT
|
|
|
Everest Medicines Receives Shareholding Increase from Substantial Shareholder CBC Group, Global Expansion Expected to Benefit
May 22, 2026 11:05: JST
|
|
|
雲頂新耀獲主要股東康橋資本增持 全球化佈局有望持續受益
May 22, 2026 10:59 HKT/SGT
|
|
|
GTJAI Won Two Awards at HR Asia 2026
May 22, 2026 10:49 HKT/SGT
|
|
|
國泰君安國際斬獲HR Asia 2026年度兩項大獎
May 22, 2026 10:49 HKT/SGT
|
|
|
国泰君安国际斩获HR Asia 2026年度两项大奖
May 22, 2026 10:49 HKT/SGT
|
|
|
Everest Medicines Receives Shareholding Increase from Substantial Shareholder CBC Group, Global Expansion Expected to Benefit
May 22, 2026 10:05 HKT/SGT
|
|
|
云顶新耀获主要股东康桥资本增持 全球化布局有望持续受益
May 22, 2026 10:05 HKT/SGT
|
|
|
Eisai Deepens Body of Clinical Evidence for LENVIMA(R) (Lenvatinib) Across Established Indications at ASCO 2026
May 22, 2026 0:23 JST
|
|
|
Honda to Begin Sales of Super-ONE Compact EV
May 22, 2026 0:16 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
